Cargando…
Mass Spectrometry-Based Identification of MHC-Associated Peptides
Neoantigen-based immunotherapies promise to improve patient outcomes over the current standard of care. However, detecting these cancer-specific antigens is one of the significant challenges in the field of mass spectrometry. Even though the first sequencing of the immunopeptides was done decades ag...
Autores principales: | Kote, Sachin, Pirog, Artur, Bedran, Georges, Alfaro, Javier, Dapic, Irena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139412/ https://www.ncbi.nlm.nih.gov/pubmed/32110973 http://dx.doi.org/10.3390/cancers12030535 |
Ejemplares similares
-
Structural determinants of peptide-dependent TAP1-TAP2 transit passage targeted by viral proteins and altered by cancer-associated mutations
por: Padariya, Monikaben, et al.
Publicado: (2021) -
The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
por: Bedran, Georges, et al.
Publicado: (2023) -
Fast and Simple Protocols for Mass Spectrometry-Based
Proteomics of Small Fresh Frozen Uterine Tissue Sections
por: Dapic, Irena, et al.
Publicado: (2017) -
Comparative Quantitative Mass Spectrometry Analysis of MHC Class II-Associated Peptides Reveals a Role of GILT in Formation of Self-Peptide Repertoire
por: Bogunovic, Branka, et al.
Publicado: (2010) -
Accelerating the scoring module of mass spectrometry-based peptide identification using GPUs
por: Li, You, et al.
Publicado: (2014)